Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05326516
Title A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Syndax Pharmaceuticals
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST